You are here
IFYBER LLC
UEI: SWJHU7YPRAU9
# of Employees: 23
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Standard-issue Antimicrobial Combat Burn Gauze
Amount: $2,195,570.00The purpose of the continuation of this Direct-to-Phase II effort is to develop a field-expedient, antimicrobial, hydration-providing wound dressing for acute care of large burn wounds.
SBIRPhase II2022Department of Defense Defense Health Agency -
Rapid field testing of field water samples for total coliform and E. coli using isothermal amplification and unique micron-sized particles for cell capture and concentration
Amount: $999,285.00iFyberLLC proposes to develop acoliform assay with differential detection of E.coliand total coliform that will circumvent thecurrent challenges with detectingthese organismsatalevel of1 CFU per100mLi ...
SBIRPhase II2020Department of Defense Defense Health Agency -
Development of wound care formulations for PVP/NO: A novel nitric oxide releasing platform with potent antimicrobial and anti-biofilm properties
Amount: $299,356.00The central goal of this SBIR research effort is to advance and commercialize a novel biomaterial with a nitric oxide (NO)-based delivery system for the wound care market. This Phase I proposal will b ...
SBIRPhase I2020Department of Health and Human Services National Institutes of Health -
Development of Novel Broad Spectrum Antimicrobial Corneal Tissue Storage Solutions
Amount: $149,858.00Endophthalmitis is a severe condition caused by inflammation of the ocular cavity and is a significant complication of corneal transplant proceduresoften being caused by microbial contamination of the ...
SBIRPhase I2018Department of Health and Human Services Centers for Disease Control and Prevention -
A Nitric Oxide Polymer Platform for the Prevention and Treatment of Infected Wounds
Amount: $255,827.00This proposed SBIR research effort will lay the foundation for commercializing a new class of biomaterial for the prevention and treatment of infected skin wounds thereby enhancing patient health thr ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Peptide based wound dressing for prevention and management of infected wounds
Amount: $215,957.00Project Summary The proposed SBIR Phase I research effort will provide foundational data for the development and commercialization of a novel wound dressing for prevention and treatment of infected sk ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Rapid field testing of field water samples for total coliform and E. coli using isothermal amplification and unique micro-sized particles for cell capture and concentration
Amount: $149,841.00iFyber LLC proposes to develop a coliform assay with differential detection of E. coli that will circumvent the current challenges with detecting these organisms at a level of 1 CFU/mL in less than 16 ...
SBIRPhase I2017Department of Defense Defense Health Agency -
SBIR Phase I: A Nitric Oxide-Releasing Polymer Platform for Wound Biofilm Management
Amount: $150,000.00This Small Business Innovation Research (SBIR) Phase I project aims to develop a topical formulation incorporating a polymeric platform that releases therapeutic levels of nitric oxide gas, and assess ...
SBIRPhase I2013National Science Foundation -
A new class of biodegradable synthetic biomaterial for seroma prevention
Amount: $231,696.00DESCRIPTION (provided by applicant): Seromas are a common post-operative complication particularly prevalent following ablative and reconstructive surgeries. Without timely intervention post-operative ...
STTRPhase I2012Department of Health and Human Services National Institutes of Health -
SBIR Phase I: Nanoparticle Antimicrobial Coatings on Natural Scaffolds for Tissue Reconstruction
Amount: $150,000.00This Small Business Innovation Research Phase I project addresses the important problem of combating hospital acquired infections with the development of novel tissue matrices aimed at preventing noso ...
SBIRPhase I2011National Science Foundation
